Phenotypic approach to the Management of chronic prostatitis/chronic pelvic pain syndrome

被引：14

作者：

Nickel J.C. ^{[1
]}

Shoskes D. ^{[1
]}

机构：

[1] Department of Urology, Queen's University, Kingston General Hospital, Kingston, ON K7L 2V7

来源：

Current Urology Reports | 2009年 / 10卷 / 4期

基金：

美国国家卫生研究院;

关键词：

Pregabalin; Prostatitis; Tamsulosin; Interstitial Cystitis; Chronic Prostatitis;

D O I：

10.1007/s11934-009-0050-7

中图分类号：

学科分类号：

摘要：

There is no one unifying etiological mechanism or specific curative therapy for chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS). However, there is sufficient evidence to suggest that each of the proposed mechanisms may be important in some patients, and that many of our evaluated treatments do in fact work in subgroups of patients. We hypothesize that CP/CPPS patients are not a homogenous group suffering from a single disease entity. Rather, CP/CPPS patients are actually unique individuals with differing clinical phenotypes based on various etiological mechanisms with distinctive symptom complexes and progression trajectories. We call this the "Snow Flake Hypothesis." We propose the UPOINT (urinary, psychosocial, organ-specific, infection, neurologic/systemic, and tenderness domains) clinical phenotyping classification; we have validated the concept in a CP/CPPS cohort and have suggested that phenotypically directed therapy will improve our clinical treatment outcomes. Copyright © 2009 by Current Medicine Group LLC.

引用

页码：307 / 312

页数：5

共 26 条

[1]

McNaughton-Collins M., Joyce G.F., Wise M., Et al., Prostatitis, Urologic Diseases in America, pp. 9-41, (2007)

[2]

Calhoun E.A., The economic impact of chronic prostatitis, Archives of Internal Medicine, 164, 11, pp. 1231-1236, (2004)

[3]

McNaughton-Collins M., Pontari M.A., O'Leary M.P., Calhoun E.A., Santanna J., Landis J.R., Kusek J.W., Litwin M.S., Schaeffer A.J., Bennet C.L., Bushman W., Duncan J.L., Koch A.E., Nadler R.B., Rhodes D., Spolarich-Kroll J., Barry M.J., Nickel J.C., Ardern D., Clark J., Downey J., Johnston B., Jarvi K., Burrows L.L., Wang W., Ruggiere M.R., Kish L., Filer-Maerten S., Shoskes D., Xie Y., Alexander R.B., Ponniah S., Byron E.B., Propert K.J., Farrar J.T., Feldman H.I., Cifelli D., Durborow S., Gon

[4]

Shoskes D.A., Nickel J.C., Rackley R.R., Pontari M.A., Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: A management strategy for urologic chronic pelvic pain syndromes, Prostate Cancer Prostatic Dis, (2009)

[5]

Shoskes D.A., Nickel J.C., Dolinga R., Prots D., Clinical phenotyping of chronic prostatitis/chronic pelvic pain patients and correlation with symptom severity, Urology, 73, pp. 538-543, (2009)

[6]

Nickel J.C., Wein A.J., Kavoussi L.R., Novick A.C., Et al., Inflammatory conditions of the male genitourinary tract: Prostatitis and related conditions, orchitis, and epididymitis, Campbell-Walsh Urology, pp. 330-370, (2006)

[7]

Krieger J.N., Nyberg L., Nickel J.C., NIH consensus definition and classification of prostatitis [5], Journal of the American Medical Association, 282, 3, pp. 236-237, (1999)

[8]

Nickel J.C., Nyberg L.M., Hennenfent M., Research guidelines for chronic prostatitis: Consensus report from the first National Institutes of Health International Prostatitis Collaborative Network, Urology, 54, 2, pp. 229-233, (1999)

[9]

Litwin M.S., McNaughton-Collins M., Fowler Jr. F.J., Nickel J.C., Calhoun E.A., Pontari M.A., Alexander R.B., Farrar J.T., O'Leary M.P., Alexander R.B., Landis J.R., Litwin M.S., Nickel J.C., O'Leary M.P., Pontari M.A., Schaeffer A.J., Barry M.J., Bennett C.L., Bushman W., Calhoun E.A., Ceri H., Cifelli D., Duncan J., Farrar J.T., Feldman H.I., Fowler Jr. F.J., Hunter D., Jarvi K., Kusek J., McNaughton-Collins M., Nadler R.B., Nyberg L.M., Ponniah S., Propert K.J., Ruggieri M.R., Shoskes D.A.,

[10]

Nickel J.C., Downey J., Clark J., Casey R.W., Pommerville P.J., Barkin J., Steinhoff G., Brock G., Patrick A.B., Flax S., Goldfarb B., Palmer B.W., Zadra J., Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: A randomized placebo-controlled multicenter trial, Urology, 62, 4, pp. 614-617, (2003)

← 1 2 3 →